Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Carnitine and type 2 diabetes

Carnitine and type 2 diabetes Studies in humans and animals demonstrate that “lipid over supply” causes or worsens insulin resistance via multiple mechanisms involving the accumulation of intracellular lipids in multiple tissues. In particular, the accumulation of fatty acyl CoA derivatives/metabolites in muscle inhibits both insulin signaling and glucose oxidation. Therefore agents that ameliorate the accumulation of fatty acyl CoA derivatives and/or their metabolites would be beneficial in the treatment or prevention of insulin resistance and T2D. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Diabetes/Metabolism: Research and Reviews Wiley

Loading next page...
 
/lp/wiley/carnitine-and-type-2-diabetes-axgBwmaIR6

References (33)

Publisher
Wiley
Copyright
Copyright © 2009 Wiley Subscription Services, Inc., A Wiley Company
ISSN
1520-7552
eISSN
1520-7560
DOI
10.1002/dmrr.987
pmid
19662615
Publisher site
See Article on Publisher Site

Abstract

Studies in humans and animals demonstrate that “lipid over supply” causes or worsens insulin resistance via multiple mechanisms involving the accumulation of intracellular lipids in multiple tissues. In particular, the accumulation of fatty acyl CoA derivatives/metabolites in muscle inhibits both insulin signaling and glucose oxidation. Therefore agents that ameliorate the accumulation of fatty acyl CoA derivatives and/or their metabolites would be beneficial in the treatment or prevention of insulin resistance and T2D.

Journal

Diabetes/Metabolism: Research and ReviewsWiley

Published: Sep 1, 2009

Keywords: ; ; ;

There are no references for this article.